In vitro activity of paldimycin (U-70138F) against gram-positive bacteria isolated from patients with cancer
- 1 April 1987
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 31 (4) , 650-652
- https://doi.org/10.1128/aac.31.4.650
Abstract
The in vitro activity of paldimycin, a novel antimicrobial agent, was compared with that of vancomycin against 306 gram-positive isolates (representing 12 bacterial species) obtained from patients with cancer. Paldimycin had lower MICs for 90% of isolates than vancomycin did against most isolates tested. Its activity, however, was medium and pH dependent, being greatest in Nutrient broth at a pH of 6.8.This publication has 5 references indexed in Scilit:
- Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemiaThe American Journal of Medicine, 1986
- Neutropenia, fever, and infectionThe American Journal of Medicine, 1984
- Identification of Staphylococcus species with the API STAPH-IDENT systemJournal of Clinical Microbiology, 1982